21063 ⎘
Medicinal preparations containing antigens or antibodies; Vertebrate antigens Antigens related to auto-immune diseases; Preparations to induce self-tolerance
Breaking immunological tolerance with a genetically encoded unnatural amino acid
#902Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
#903DNA vaccines encoding heat shock proteins
#904Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases
#905USES OF BISPECIFIC ANTIBODY COATED DENDRITIC CELLS PULSED WITH ANTIGENS AND GM-CSF IN IMMUNE REGULATION
#906Vaccine Compositions for Inducing Immune Responses Against Components of Drusen
#907Methods and Agents to Treat Autoimmune Diseases
#908COMPOUND COMPRISING AN AUTOANTIGENIC PEPTIDE AND A CARRIER WITH A MHC BINDING MOTIF
#909METHODS OF MHC CLASS II EPITOPE MAPPING, DETECTION OF AUTOIMMUNE T CELLS AND ANTIGENS, AND AUTOIMMUNE TREATMENT
#910Prophylactic and/or Therapeutic Method for Treatment of Autoimmune Disease
#911Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
#912Eye-drop vaccine containing copolymer 1 for therapeutic immunization
#913Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#914Chimeric, humanized, or human antibody 2A4
#915Type IV collagen-like immunoreactive peptide
#916USE OF IMMATURE DENDRITIC CELLS TO SILENCE ANTIGEN SPECIFIC CD8+ T CELL FUNCTION
#917Mycobacterial Catalase-Peroxidase in the Diagnosis and Treatment of Sarcoidosis
#918Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
#919Tolerizing agents
#920THERAPEUTIC USES OF GLANDULAR KALLIKREIN
#921Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#922Compositions and methods for the prevention and treatment of autoimmune conditions
#923Induction of mucosal tolerance to antigens
#924Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells
#925Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof
#926Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses
#927Il-15 Antigen Arrays And Uses Thereof
#928Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis
#929T-CELL MODULATION
#930COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS
#931Composition and method for treating autoimmune disease and mucosal disorder
#932Medicaments and methods to treat autoimmune disease and cancer
#933Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
#934Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#935Obtention of food- or auto-antigen specific TR1 cells from a leukocyte or PBMC population
#936Specific Inhibition of Autoimmunity and Diseases Associated With Autoantigens
#937Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
#938Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
#939Regulatory T cell epitopes, compositions and uses thereof
#940Composition and method for prevention and treatment of type I diabetes
#941Methods for detecting and treating autoimmune disorders
#942TLR AGONIST (FLAGELLIN)/CD40 AGONIST/ANTIGEN PROTEIN AND DNA CONJUGATES AND USE THEREOF FOR INDUCING SYNERGISTIC ENHANCEMENT IN IMMUNITY
#943INDUCTION OF IMMUNOLOGICAL TOLERANCE
#944Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
#945CHEMICALLY-DEFINED NON-POLYMERIC VALENCY PLATFORM MOLECULES AND CONJUGATES THEREOF
#946Methods and compositions involving polymeric immunoglobulin fusion proteins
#947Disease Prevention and Vaccination Prior to Thymic Reactivation
#948Iron-Containing Human Milk Fortifier With Improved Antimicrobial Properties
#949Chloroplasts Engineering to Express Pharmaceutical Proteins
#950Molecular antigen arrary
#951Therapeutic vaccine
#952Peptide inhibitors for mediating stress responses
#953METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS
#954Antiangiogenic active immunotherapy
#955DNA vaccine
#956Treatment and prevention of vascular dementia
#957METHOD FOR OBTAINING ANTIGEN-SPECIFIC TR1 REGULATORY LYMPHOCYTES
#958BREAST CANCER ERADICATION PROGRAM
#959Synthetic peptides and methods of use for autoimmune disease therapies
#960Methods and compositions to treat misfolded-SOD1 mediated diseases
#961Peptide composition
#962Stimulation of thymus for vaccination development
#963Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
#964Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira Infection
#965Substances for preventing and treating autoimmune diseases
#966SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES
#967Novel Goodpasture Antigen-Binding Protein Isoforms and Protein Misfolded-Mediated Disorders
#968CD127 expression inversely correlates with FoxP3 and suppressive function of CD4Tregs
#969Treatment of Inappropriate Immune Responses
#970Activation and inhibition of the immune system
#971DNA vaccination for treatment of autoimmune disease
#972Method For Increasing Cd8+ Cytotoxic T Cell Responses And For Treating Multiple Sclerosis
#973Tr1 cells for use in atherosclerosis
#974Identification of self and non-self antigens implicated in autoimmune disease
#975Vaccine And Method For Treatment Of Neurodegenerative Diseases
#976Prevention of primary sjogren' s Syndrome by ICA69 deficiency
#977Method for Treating Autoimmune Diseases With Antibodies
#978Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3
#979Cancer immunotherapy compositions and methods of use
#980Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
#981Compositions and methods for immunotherapy
#982TREATMENT OF AUTOIMMUNE DISORDERS
#983Cd25 Dna Vaccines for Treating and Preventing T-Cell Mediated Diseases
#984RECOMBINANT FRAGMENTS OF THE HUMAN ACETYLCHOLINE RECEPTOR AND THEIR USE FOR TREATMENT OF MYASTHENIA GRAVIS
#985Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BAFFR
#986Peptides for Treatment of Autoimmune Disease
#987Chemically-defined non-polymeric valency platform molecules and conjugates thereof
#988Methods for preventing strokes by inducing tolerance to E-selectin
#989Heparanase-derived peptides for vaccination of tumor patients
#990Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
#991Immunomodulating Compositions, Uses Therefore and Processes for Their Production
#992Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
#993Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
#994Therapeutic vaccine compositions for the treatment of type 1 diabetes
#995Therapeutic uses of glandular kallikrein
#996Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders
#997Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal
#998METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF DIABETES TREATMENT
#999Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation
#1000Superantigen conjugate
#1001Methods and compositions for expanding T regulatory cells
#1002Allergy inhibitor compositions and kits and methods of using the same
#1003Development of influenza A antivirals
#1004Formulation of antigen
#1005METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF DIABETES TREATMENT
#1006METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF DIABETES TREATMENT
#1007Immunotherapy method
#1008Compositions and methods of treatment
#1009Antigen arrays for treatment of bone disease
#1010Hox11+, CD45− cells and methods of organ regeneration using the same
#1011Immune modulator
#1012Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
#1013Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
#1014Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
#1015Antigen arrays for treatment of allergic eosinophilic diseases
#1016Arthritis vaccines and methods
#1017Angiotensin peptide-carrier conjugates and uses thereof
#1018PRAME peptide analogues
#1019Melanoma antigen peptide analogues
#1020PSMA peptide analogues
#1021Molecular antigen array
#1022Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases
#1023Compositions and methods for inactivating or suppressing inflammatory cells
#1024Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#1025Anti-allergic complex molecules
#1026Low dose histone peptide treatment for autoimmune disorders
#1027Methods and compositions for treating and preventing inflammatory conditions
#1028Methods of expanding and selecting disease associated T-Cells
#1029Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
#1030Composition and method for treating autoimmune disease and mucosal disorder
#1031Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
#1032Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases
#1033T cell receptor CDR3 sequences associated with multiple sclerosis and compositions comprising same
#1034Regulatory T cells suppress autoimmunity
#1035Compositions and methods for treating neurological disorders
#1036Induction of immune response to antigens expressed by recombinant adeno-associated virus
#1037Isolation and identification of cross-reactive t cells
#1038Methods and compositions for induction or promotion of immune tolerance
#1039Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
#1040Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#1041Insulin B chain autoantigen composition
#1042Immunomodulating compositions, processes for their production and uses therefor
#1043Stress proteins and uses therefor
#1044Stress proteins and uses therefor
#1045H-Y antigen
#1046Identification of self and non-self antigens implicated in autoimmune diseases
#1047Method of treating an autoimmune disease
#1048DNA immunization with recombinase/transposase
#1049Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
#1050Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
#1051Activation of regulatory T cells by alpha-melanocyte stimulating hormone
#1052Immunosuppressive exosomes
#1053Methods of generating antigen-specific CD4+CD25+regulatory T cells, compositions and methods of use
#1054Preventives/remedies for neurodegenerative diseases
#1055Vaccine composition comprising methylated DNA and immunomodulatory motifs
#1056Plant bioreactors
#1057Isolation and identification of T cells
#1058Vaccine comprising il-13 and an adjuvant
#1059Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of prophylaxis and treatment of avian influenza
#1060Tolerogenic vaccine and method
#1061Methods for epitope-specific and cytokine/anticytokine combination immunotherapies
#1062Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
#1063DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
#1064Angiotensin peptide-carrier conjugates and uses thereof
#1065Prevention of primary Sjogren's Syndrome by ICA69 deficiency
#1066Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#1067Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#1068Anti-IgE vaccines
#1069Method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of interstitial cystitis treatment; method of acquired immune deficiency syndrome treatment; and method of herpes treatment
#1070Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#1071Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#1072Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of interstitial cystitis treatment; method of acquired immune deficiency syndrome treatment; and method of herpes treatment
#1073Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#1074Antigenic fragments of human factor VIII polypeptides
#1075Vaccines for autoimmune and infectious disease
#1076Medicaments containing bisphosphonic acids and derivatives thereof for preventing and treating diseases and allergies
#1077Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same
#1078Treatment methods for eotaxin mediated inflammatory conditons
#1079Methods and compositions for detecting and treating autoimmune diseases
#1080Peptide composition as immunogen for the treatment of allergy
#1081Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
#1082Substances for preventing and treating autoimmune diseases
#1083Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
#1084Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
#1085Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
#1086Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides
#1087Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
#1088aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
#1089Treatment of autoimmune diseases by oral administration of autoantigens
#1090Methods of blocking tissue destruction by autoreactive T cells
#1091Methods of blocking tissue destruction by autoreactive T cells
#1092Methods of blocking tissue destruction by autoreactive T cells
#1093Disease therapy using dying or dead cells
#1094Identification of self and non-self antigens implicated in autoimmune diseases
#1095Use of neglected target tissue antigens in modulation of immune responses
#1096Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24
#1097DNA vaccines encoding heat shock proteins
#1098Induction of antigen specific immunologic tolerance
#1099Regulatory T cells suppress autoimmunity
#1100Autologous T-cell vaccines materials and methods
#1101Active antiangiogenic therapy
#1102Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#1103Stress proteins and uses therefor
#1104Targeting antigen-specific T cells for specific immunotherapy of autoimmune disease
#1105Methods of therapy
#1106Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
#1107Methods of organ regeneration using -expressing pluripotent cells
#1108Formulation of antigen
#1109Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
#1110Therapeutic properties of oils
#1111Methods of monitoring immunization
#1112Educated NKT cells and their uses in the treatment of immune-related disorders
#1113Antigen presenting vesicles
#1114Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#1115Induction of tolerance by apoptotic and/or necrotic cells
#1116Chemically defined non-polymeric valency platform molecules and conjugates thereof
#1117Method and compositions for treatment of insulin-dependant diabetes mellitus
#1118Regulating immune response using dendritic cells
#1119T cell receptor CDR3 sequence and methods for detecting and treating rheumatoid arthritis